Considering the population and ethnic heterogeneity in the distribution of HPA polymorphisms and their possible pathogenic capacity, it is recommended to evaluate the role of HPA polymorphisms as risk factors for thrombocytopenia in different populations with COVID-19. This evidence concerns the gene HPSE and Thrombocytopenia.